6861:TSEKeyence Corporation Analysis
Data as of 2026-05-24 - not real-time
NT$449.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
InnoCare Optoelectronics is trading at TWD 449, just 4% below its 52‑week high of 490 and well above its 20‑day SMA of 381, indicating a strong bullish price trend. However, the RSI of 72 signals an overbought condition and the MACD has turned bearish (line below signal, negative histogram), while volume is on a decreasing trend, suggesting short‑term momentum may be waning.
Fundamentally, the company posted a 47% YoY revenue surge and maintains solid profitability (operating margin 11%, profit margin 8%) with a healthy cash position (≈ TWD 909 M) and modest debt. Yet the market is pricing the stock at a PE of 119 versus an industry average of 27, and the DCF‑derived fair value of ~196 is less than half the current price, flagging significant overvaluation. The dividend yield is modest at 0.4% with a payout ratio under 50%, implying sustainability. Overall, the stock reflects extreme market optimism (Fear & Greed Index 91.6) but carries elevated valuation and volatility risks.
Fundamentally, the company posted a 47% YoY revenue surge and maintains solid profitability (operating margin 11%, profit margin 8%) with a healthy cash position (≈ TWD 909 M) and modest debt. Yet the market is pricing the stock at a PE of 119 versus an industry average of 27, and the DCF‑derived fair value of ~196 is less than half the current price, flagging significant overvaluation. The dividend yield is modest at 0.4% with a payout ratio under 50%, implying sustainability. Overall, the stock reflects extreme market optimism (Fear & Greed Index 91.6) but carries elevated valuation and volatility risks.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- RSI in overbought territory
- Bearish MACD crossover
- Decreasing trading volume
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Robust 47% revenue growth
- PE far above industry norm
- Large gap between market price and DCF fair value
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustained cash generation and low debt
- Dividend sustainability with sub‑50% payout
- Industry tailwinds for medical imaging and optoelectronics
Key Metrics & Analysis
Financial Health
Revenue Growth47.40%
Profit Margin8.03%
P/E Ratio119.1
ROE13.71%
ROA4.59%
Debt/Equity7.22
P/B Ratio12.8
Op. Cash FlowNT$275.1M
Free Cash FlowNT$207.1M
Industry P/E27.6
Technical Analysis
TrendBullish
RSI72.1
SupportNT$234.00
ResistanceNT$490.00
MA 20NT$381.28
MA 50NT$245.21
MA 200NT$110.12
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
Fair ValueNT$196.20
GradeOvervalued
TypeGrowth
Dividend Yield0.40%
Risk Assessment
Beta0.70
Volatility91.52%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.